Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹746.85. The stock has experienced fluctuations today, with a low ...

Tata Equity P/E Fund - (G) 135.15 16,92,000 1.69 Tata Equity P/E Fund-(IDCW-Trigger-Opt B-10%) 135.15 16,92,000 1.69 Tata Equity P/E Fund - (IDCW-Trigger - Opt A - 5% ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,823.13 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

Natco Pharma Ltd share price was up by 3.88% from the previous closing price of ₹746.50. Who are peers of Natco Pharma Ltd? The peers of Natco Pharma Ltd are Sun Pharmaceutical Industries Ltd ...

Natco Pharma Ltd现在的股价报826.25 Natco Pharma Ltd的股票在哪间交易所挂牌交易？ Natco Pharma Ltd的股票在印度NSE挂牌交易。 Natco Pharma Ltd的股票代码是什么？ Natco Pharma Ltd的股票代码是“NATP。” Natco Pharma Ltd有分红吗？当前的股息收益率是多少？ Natco Pharma ...

Competition page helps you compare Natco Pharma Ltd. with its sector peers on key parameters.

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

Natco Pharma started in Hyderabad with an investment of ₹3.3 million in 1981 and 20 employees working at a single unit. Today, the company has 8 manufacturing units in Dehradun, Nagarjuna Sagar, ...

A division bench of the Delhi High Court on Wednesday asked Natco Pharma to pause the launch of its drug Risdiplam till April 2 amid a patent dispute with Swiss pharmaceutical giant F Hoffmann-La ...

Natco Pharma has decided to price Risdiplam, indicated for the treatment of rare genetic disorder Spinal Muscular Atrophy (SMA), at₹15,900. In an update on the legal proceedings on the ...